跳至主要内容
临床试验/JPRN-jRCT2032220135
JPRN-jRCT2032220135进行中(未招募)3 期

ExtraVascular Implantable Cardioverter Defibrillator (EV ICD) Japan Study

Yamamoto Takuto0 个研究点目标入组 15 人开始时间: 2022年6月15日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • 1.Patient has a Class I or IIa indication for implantation of an ICD according to the ACC/AHA/HRS Guidelines, or ESC guidelines.
  • 2.Patient is at least 18 years of age and meets age requirements per local law.
  • 3.Patient is geographically stable and willing and able to complete the study procedures and visits for the duration of the follow-up.

排除标准

  • 1.Patient is unwilling or unable to personally provide Informed Consent.
  • 2.Patient has indications for bradycardia pacing or Cardiac Resynchronization Therapy (CRT) (Class I, IIa, or IIb indication).
  • 3.Patients with an existing pacemaker, ICD, or CRT device implant or leads.
  • 4.Patients with these medical interventions are excluded from participation in the study:
  • -Prior sternotomy
  • -Any prior medical condition or procedure that leads to adhesions in the anterior mediastinal space (i.e., prior mediastinal instrumentation, mediastinitis)
  • -Prior abdominal surgery in the epigastric region
  • -Planned sternotomy
  • -Prior chest radiotherapy
  • Or any other prior/planned medical intervention not listed that precludes their participation in the opinion of the Investigator.
  • 5.Patient has previous pericarditis that:
  • -Was chronic and recurrent, or
  • -Resulted in pericardial effusion, or
  • -Resulted in pericardial thickening or calcification.
  • 6.Patients with these medical conditions or anatomies are excluded from participation in the study:
  • -Hiatal hernia that distorts mediastinal anatomy
  • -Marked sternal abnormality (e.g., pectus excavatum)
  • -Decompensated heart failure
  • -COPD with oxygen dependence
  • -Gross hepatosplenomegaly
  • Or any other known medical condition or anatomy type not listed that precludes their participation in the opinion of the Investigator.
  • 7.Patients with a medical condition that precludes them from undergoing defibrillation testing:
  • -Severe aortic stenosis
  • -Intracardiac LA or LV thro
  • -Severe proximal three-vessel or left main coronary artery disease without revascularization
  • -Hemodynamic instability
  • -Unstable angina
  • -Recent stroke or transient ischemic attack (within the last 6 months)
  • -Known inadequate external defibrillation
  • -LVEF < 20%
  • -LVEDD >70 mm
  • Or any other known medical condition not listed that precludes their participation in the opinion of the Investigator.
  • 8.Patient with any evidence of active infection or undergoing treatment for an infection
  • 9.Patient is contraindicated from temporary suspension of oral/systemic anticoagulation
  • 10.Patient with current implantation of neurostimulator or any other chronically implanted device that delivers current in the body.
  • 11.Patient meets ACC/AHA/HRS or ESC clinical guideline Class III criteria for an ICD (e.g., life expectancy of less than 12 month).
  • 12.Patient is enrolled or planning to enroll in a concurrent clinical study that may confound the results of this study, without documented pre-approval from a Medtronic study manager.
  • 13.Patient with any exclusion criteria as required by local law (e.g., age or other).
  • 14.Pregnant women or breastfeeding women, or women of child bearing potential and who are not on a reliable form of birth regulation method or abstinence.

研究者

发起方
Yamamoto Takuto

相似试验